EUVIMEDEUVIMED entdecken
Crossref

Antimicrobial and anti-virulence effects of functionalized cobalt nanoparticles against multidrug-resistant Escherichia coli causing urinary tract infections

Omar H Raoof, Thamer Y Mutter, Abdurrahman Ayvaz

Microbial Pathogenesis · 2025

DOI: 10.1016/j.micpath.2025.108101 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Microbial Pathogenesis, 2025. Verfasst von Omar H Raoof und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Erciyes University, 38039, Kayseri, Turkey. Hauptthemen laut MEDLINE: Cobalt, Urinary Tract Infections, Escherichia coli, Drug Resistance, Multiple, Bacterial. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 43 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing prevalence of multidrug-resistant (MDR) Escherichia coli and its ability to form biofilms pose a significant public health threat, particularly in urinary tract infections (UTIs). This study aimed to investigate the antibacterial, antibiofilm, and gene expression-modulating effects of gallic acid-stabilized cobalt nanoparticles (Co-GANPs) and their hyaluronic acid-modified versions (Co-GANPs-HA) against clinical E. coli isolates obtained from Ramadi Children's and Gynecology Hospital and Hit General Hospital. Nanoparticles were successfully synthesized and characterized using techniques such as XRD, FT-IR, SEM, TEM, and EDX. Physicochemical analyses confirmed the production of stable, spherical, and well-dispersed nanostructures with a crystallite size of 8.8 nm. Biological evaluations demonstrated that Co-GANPs-HA exhibited superior antibacterial activity compared to Co-GANPs, with a lower Minimum Inhibitory Concentration (MIC) of 3.1 mg/mL versus 6.2 mg/mL. The nanoparticles effectively inhibited both planktonic cells and biofilm formation, including in antibiotic-resistant isolates. Gene expression analysis revealed that both nanoparticle formulations significantly downregulated the expression of qclb, a key virulence gene. These findings suggest that functionalized cobalt nanoparticles, with their multifactorial mechanism of action that bypasses traditional resistance, could be a powerful therapeutic alternative or adjunct for MDR and biofilm-related UTIs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CobaltUrinary Tract InfectionsEscherichia coliDrug Resistance, Multiple, BacterialAnti-Bacterial AgentsMetal NanoparticlesNanoparticlesBiofilmsMicrobial Sensitivity TestsHumansEscherichia coli InfectionsVirulenceGene Expression Regulation, Bacterial

Stichwörter der Autor:innen

AntimicrobialBiofilmCobaltEscherichia coliMultidrug resistanceNanoparticlesUrinary tract infections

Substanzen

CobaltAnti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Biology, Erciyes University, 38039, Kayseri, Turkey.
  • Department of Biology, College of Science, University of Anbar, Anbar, Iraq. Electronic address: mthamir78@uoanbar.eud.iq.

Zitieren

APA

Raoof, O. H., Mutter, T. Y., & Ayvaz, A. (2025). Antimicrobial and anti-virulence effects of functionalized cobalt nanoparticles against multidrug-resistant Escherichia coli causing urinary tract infections. Microbial Pathogenesis. https://doi.org/10.1016/j.micpath.2025.108101

Vancouver

Raoof OH, Mutter TY, Ayvaz A. Antimicrobial and anti-virulence effects of functionalized cobalt nanoparticles against multidrug-resistant Escherichia coli causing urinary tract infections. Microbial Pathogenesis. 2025. doi:10.1016/j.micpath.2025.108101

BibTeX
@article{Raoof2025,
  author = {Raoof, Omar H and Mutter, Thamer Y and Ayvaz, Abdurrahman},
  title = {Antimicrobial and anti-virulence effects of functionalized cobalt nanoparticles against multidrug-resistant Escherichia coli causing urinary tract infections},
  journal = {Microbial Pathogenesis},
  year = {2025},
  doi = {10.1016/j.micpath.2025.108101}
}
Kostenlos starten →